NORTH CHICAGO, Ill.,
Nov. 13, 2018 /PRNewswire/ -- AbbVie
(NYSE: ABBV), a research-based global biopharmaceutical company,
will participate in the Evercore ISI HealthConX Conference
on Tuesday, November 27, 2018. Bill
Chase, executive vice president, finance and administration,
will present at 8 a.m. Eastern time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie is a global, research and development-based
biopharmaceutical company committed to developing innovative
advanced therapies for some of the world's most complex and
critical conditions. The company's mission is to use its expertise,
dedicated people and unique approach to innovation to markedly
improve treatments across four primary therapeutic areas:
immunology, oncology, virology and neuroscience. In more than
75 countries, AbbVie employees are working every day to advance
health solutions for people around the world. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, LinkedIn or Instagram.
View original
content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-conference-300748709.html
SOURCE AbbVie